TY - JOUR
T1 - Consensus statements from the International Society for Heart and Lung Transplantation consensus conference
T2 - Heart failure–related cardiogenic shock
AU - Baran, David A.
AU - Billia, Filio
AU - Randhawa, Varinder
AU - Cowger, Jennifer A.
AU - Barnett, Christopher M.
AU - Chih, Sharon
AU - Ensminger, Stephan
AU - Hernandez-Montfort, Jaime
AU - Sinha, Shashank S.
AU - Vorovich, Esther
AU - Proudfoot, Alastair
AU - Lim, Hoong Sern
AU - Blumer, Vanessa
AU - Jennings, Douglas L.
AU - Reshad Garan, A.
AU - Renedo, Maria Florencia
AU - Hanff, Thomas C.
AU - Kanwar, Manreet K.
AU - Overgaard, Chris
AU - Teuteberg, Jeffrey
AU - Rosner, Carolyn
AU - Nagpal, Dave
AU - Taimeh, Ziad
AU - Abraham, Jacob
AU - Ton, Van Khue
AU - Drakos, Stavros
AU - Tehrani, Behnam
AU - Bernhardt, Alexander
AU - Meeran, Talha
AU - Douglas Greig, P.
AU - Farrero, Marta
AU - Katz, Jason
AU - Luk, Adriana
AU - Bennett, Courtney
AU - Bertolotti, Alejandro
AU - Tedford, Ryan J.
AU - Cogswell, Rebecca
AU - Klein, Liviu
AU - Guerrero-Miranda, Cesar Y.
AU - Rampersad, Penelope
AU - Potena, Luciano
AU - Boeken, Udo
AU - Copeland, Hannah
AU - Hall, Shelley
AU - González-Costello, José
AU - Kapur, Navin K.
AU - Loforte, Antonio
AU - Burkhoff, Daniel
AU - LePrince, Pascal
AU - Gustafsson, Finn
AU - Uriel, Nir
AU - Kataria, Rachna
AU - Arora, Sonali
AU - Masetti, Marco
AU - Saeed, Diyar
N1 - Publisher Copyright:
© 2023 International Society for the Heart and Lung Transplantation
PY - 2024/2
Y1 - 2024/2
N2 - The last decade has brought tremendous interest in the problem of cardiogenic shock. However, the mortality rate of this syndrome approaches 50%, and other than prompt myocardial revascularization, there have been no treatments proven to improve the survival of these patients. The bulk of studies have been in patients with acute myocardial infarction, and there is little evidence to guide the clinician in those patients with heart failure cardiogenic shock (HF-CS). An International Society for Heart and Lung Transplant consensus conference was organized to better define, diagnose, and manage HF-CS. There were 54 participants (advanced heart failure and interventional cardiologists, cardiothoracic surgeons, critical care cardiologists, intensivists, pharmacists, and allied health professionals) with vast clinical and published experience in CS, representing 42 centers worldwide. This consensus report summarizes the results of a premeeting survey answered by participants and the breakout sessions where predefined clinical issues were discussed to achieve consensus in the absence of robust data. Key issues discussed include systems for CS management, including the “hub-and-spoke” model vs a tier-based network, minimum levels of data to communicate when considering transfer, disciplines that should be involved in a “shock team,” goals for mechanical circulatory support device selection, and optimal flow on such devices. Overall, the document provides expert consensus on some important issues facing practitioners managing HF-CS. It is hoped that this will clarify areas where consensus has been reached and stimulate future research and registries to provide insight regarding other crucial knowledge gaps.
AB - The last decade has brought tremendous interest in the problem of cardiogenic shock. However, the mortality rate of this syndrome approaches 50%, and other than prompt myocardial revascularization, there have been no treatments proven to improve the survival of these patients. The bulk of studies have been in patients with acute myocardial infarction, and there is little evidence to guide the clinician in those patients with heart failure cardiogenic shock (HF-CS). An International Society for Heart and Lung Transplant consensus conference was organized to better define, diagnose, and manage HF-CS. There were 54 participants (advanced heart failure and interventional cardiologists, cardiothoracic surgeons, critical care cardiologists, intensivists, pharmacists, and allied health professionals) with vast clinical and published experience in CS, representing 42 centers worldwide. This consensus report summarizes the results of a premeeting survey answered by participants and the breakout sessions where predefined clinical issues were discussed to achieve consensus in the absence of robust data. Key issues discussed include systems for CS management, including the “hub-and-spoke” model vs a tier-based network, minimum levels of data to communicate when considering transfer, disciplines that should be involved in a “shock team,” goals for mechanical circulatory support device selection, and optimal flow on such devices. Overall, the document provides expert consensus on some important issues facing practitioners managing HF-CS. It is hoped that this will clarify areas where consensus has been reached and stimulate future research and registries to provide insight regarding other crucial knowledge gaps.
KW - cardiogenic shock
KW - conference
KW - consensus
KW - management
KW - shock severity
KW - temporary mechanical circulatory support
UR - http://www.scopus.com/inward/record.url?scp=85182180234&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85182180234&partnerID=8YFLogxK
U2 - 10.1016/j.healun.2023.10.007
DO - 10.1016/j.healun.2023.10.007
M3 - Article
C2 - 38069919
AN - SCOPUS:85182180234
SN - 1053-2498
VL - 43
SP - 204
EP - 216
JO - Journal of Heart and Lung Transplantation
JF - Journal of Heart and Lung Transplantation
IS - 2
ER -